Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

1.

Evaluation of meningitis surveillance before introduction of serogroup a meningococcal conjugate vaccine - Burkina Faso and Mali.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2012 Dec 21;61(50):1025-8.

PMID:
23254257
[PubMed - indexed for MEDLINE]
Free Article
2.

Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience.

Djingarey MH, Barry R, Bonkoungou M, Tiendrebeogo S, Sebgo R, Kandolo D, Lingani C, Preziosi MP, Zuber PL, Perea W, Hugonnet S, Dellepiane de Rey Tolve N, Tevi-Benissan C, Clark TA, Mayer LW, Novak R, Messonier NE, Berlier M, Toboe D, Nshimirimana D, Mihigo R, Aguado T, Diomandé F, Kristiansen PA, Caugant DA, Laforce FM.

Vaccine. 2012 May 30;30 Suppl 2:B40-5. doi: 10.1016/j.vaccine.2011.12.073. Review.

PMID:
22607898
[PubMed - indexed for MEDLINE]
3.

Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.

Dakar discussion group on priorities for research on epidemic meningococcal disease in Africa, Altmann D, Aseffa A, Bash M, Basta N, Borrow R, Broome C, Caugant D, Clark T, Collard JM, Djingarey M, Goldblatt D, Greenwood B, Griffiths U, Hajjeh R, Hassan-King M, Hugonnet S, Kimball AM, LaForce M, MacLennan C, Maiden MC, Manigart O, Mayer L, Messonnier N, Moisi J, Moore K, Moto DD, Mueller J, Nascimento M, Obaro S, Ouedraogo R, Page AL, Perea W, Pluschke G, Preziosi MP, Sow S, Stephens D, Stuart J, Thomson M, Tiendrebeogo S, Trape JF, Vernet G.

Vaccine. 2013 Mar 1;31(11):1453-7. doi: 10.1016/j.vaccine.2012.12.035. Epub 2012 Dec 27.

PMID:
23273967
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Meningitis epidemics in Africa: a brief overview.

Teyssou R, Muros-Le Rouzic E.

Vaccine. 2007 Sep 3;25 Suppl 1:A3-7. Epub 2007 May 15. Review.

PMID:
17643560
[PubMed - indexed for MEDLINE]
5.

[Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].

du Châtelet IP, Alonso JM, Taha MK.

Bull Soc Pathol Exot. 2002 Dec;95(5):323-4; discussion 324-5. Review. French.

PMID:
12696368
[PubMed - indexed for MEDLINE]
6.

Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.

Mueller JE, Borrow R, Gessner BD.

Expert Rev Vaccines. 2006 Jun;5(3):319-36. Review.

PMID:
16827617
[PubMed - indexed for MEDLINE]
7.

[Which vaccination strategies for African meningococcal meningitis?].

Saliou P, Debois H.

Bull Soc Pathol Exot. 2002 Dec;95(5):326-30. Review. French.

PMID:
12696369
[PubMed - indexed for MEDLINE]
8.

Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM).

Frasch CE, Preziosi MP, LaForce FM.

Hum Vaccin Immunother. 2012 Jun;8(6):715-24. doi: 10.4161/hv.19619. Epub 2012 Apr 12. Review.

PMID:
22495119
[PubMed - indexed for MEDLINE]
9.

Meningococcal conjugate vaccines.

Zimmer SM, Stephens DS.

Expert Opin Pharmacother. 2004 Apr;5(4):855-63. Review.

PMID:
15102568
[PubMed - indexed for MEDLINE]
10.

Meningococcal vaccine in travelers.

Wilder-Smith A.

Curr Opin Infect Dis. 2007 Oct;20(5):454-60. Review.

PMID:
17762777
[PubMed - indexed for MEDLINE]
11.

Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.

Okoko BJ, Idoko OT, Adegbola RA.

Vaccine. 2009 Mar 23;27(14):2023-9. doi: 10.1016/j.vaccine.2008.11.092. Epub 2008 Dec 16. Review.

PMID:
19095025
[PubMed - indexed for MEDLINE]
12.

Meningococcal C conjugate vaccine: the experience in England and Wales.

Campbell H, Borrow R, Salisbury D, Miller E.

Vaccine. 2009 Jun 24;27 Suppl 2:B20-9. doi: 10.1016/j.vaccine.2009.04.067. Epub 2009 May 23. Review.

PMID:
19477053
[PubMed - indexed for MEDLINE]
13.

Meningococcal conjugate vaccines: efficacy and new combinations.

Sáfadi MA, Barros AP.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S35-44. Review.

PMID:
16826310
[PubMed - indexed for MEDLINE]
Free Article
14.

Neisseria meningitidis serogroup A vaccines: an overview.

Vergnano S, Heath P.

Expert Rev Vaccines. 2003 Aug;2(4):571-82. Review.

PMID:
14711341
[PubMed - indexed for MEDLINE]
15.

Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.

Marc LaForce F, Ravenscroft N, Djingarey M, Viviani S.

Vaccine. 2009 Jun 24;27 Suppl 2:B13-9. doi: 10.1016/j.vaccine.2009.04.062. Epub 2009 May 27. Review.

PMID:
19477559
[PubMed - indexed for MEDLINE]
16.

Quadrivalent meningococcal conjugate vaccines.

Pace D, Pollard AJ, Messonier NE.

Vaccine. 2009 Jun 24;27 Suppl 2:B30-41. doi: 10.1016/j.vaccine.2009.05.003. Epub 2009 May 27. Review.

PMID:
19477560
[PubMed - indexed for MEDLINE]
17.

Recent developments in Neisseria meningitidis group A conjugate vaccines.

Frasch CE.

Expert Opin Biol Ther. 2005 Feb;5(2):273-80. Review.

PMID:
15757388
[PubMed - indexed for MEDLINE]
18.

Prevention of bacterial meningitis: an overview of Cochrane systematic reviews.

Prasad K, Karlupia N.

Respir Med. 2007 Oct;101(10):2037-43. Epub 2007 Aug 13. Review.

PMID:
17706408
[PubMed - indexed for MEDLINE]
Free Article
19.

The epidemiology of meningococcal disease and the impact of vaccines.

Khatami A, Pollard AJ.

Expert Rev Vaccines. 2010 Mar;9(3):285-98. doi: 10.1586/erv.10.3. Review. Erratum in: Expert Rev Vaccines. 2011 Mar;10(3):398.

PMID:
20218857
[PubMed - indexed for MEDLINE]
20.

[Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa].

Chippaux JP, Debois H, Saliou P.

Bull Soc Pathol Exot. 2002 Mar;95(1):37-44. Review. French.

PMID:
12012963
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk